Pilot clinical trial in China to test University of British Columbia researcher’s findings as a targeted therapy for COVID-19
On Feb. 25, 2020, a University of British Columbia researcher was part of an international team working with…
On Feb. 25, 2020, a University of British Columbia researcher was part of an international team working with…
On Feb. 25, 2020, Vir Biotech announced a development and manufacturing collaboration to advance and produce human monoclonal…
On Feb. 24, 2020, researchers at National Institute of Allergy and Infectious Disease’s Rocky Mountain Laboratories in Hamilton,…
On Feb. 22, 2020, a federal judge from the Southern District of New York ruled drug companies, device…
On Feb. 21, 2020, Lundbeck announced that VYEPTIâ„¢ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) approved NEXLETOL (bempedoic acid) tablet, an oral,…
On Feb. 21, 2020, a $2 million gift from University of Missouri alumni will support the university’s NextGen…
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) authorized marketing of the first test to…
On Feb. 24, 2020, researchers reported that the spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia…
On Feb. 20, 2020, using a machine-learning algorithm, researchers at MIT and the Broad Institute of MIT and…
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may…
On Feb. 16, 2020, Medigen Vaccine Biologics (MVB) and the National Institutes of Health (NIH) announced they had…
On Feb. 13, 2020, a study published in Cell provided an unprecedented look at the dozens of molecular…
On Feb. 13, 2020, National Institutes of Health (NIH) scientists announced that the experimental antiviral remdesivir successfully prevented…
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
On Feb. 10, 2020, the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) announced…
On Feb. 5, 2020, The Pan-cancer analysis of whole genomes was published in Nature. The flagship paper of…
On Feb. 5, 2020, to fight further spread of the new coronavirus (2019-nCoV) outbreak in China and globally,…
On Feb. 5, 2020, an international team announced that it had completed the most comprehensive study of whole…
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
On Jan. 31, 2020, Vaxart announced it had initiated a program to develop a coronavirus vaccine candidate based…
On Jan 31, 2020, Taconic Biosciences announced that it had expanded its immuno-oncology portfolio with the launch of…
On Jan. 31, 2020, the U.S. Departments of Health and Human Services announced that as a result of…
On Jan. 30, 2020, The WHO announced that the outbreak of a deadly and fast-spreading strain of coronavirus…
On Jan. 30, 2020, the Centers for Disease Control and Prevention (CDC) confirmed that the 2019 Novel Coronavirus…
On Jan. 29, 2020, 23andMe announced an agreement with Almirall to in-license 23andMe’s bispecific monoclonal antibody designed to…
On Jan. 29, 2020, Sorrento announced it had produced a preclinical batch of the STI-4398 (COVIDTRAP) protein to…
On Jan. 28, 2020, the Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, met President…